Joint Online Session: UDI Registration in EUDAMED – Why and How to Use It Now

Rebekka Eisenacher
September 29, 2021

USDM and atrify are hosting two joint online sessions “UDI registration in EUDAMED – Why and How to use it Now” on Thursday, October 28th 2021.

October 28th – 3PM CEST/ 10AM ET                                           Register now for the free online session

October 28th – 8PM CEST/ 2PM ET                                              Register now for the free online session

The European Database on Medical Devices (EUDAMED) will no longer be a sandbox. The Device Registration and UDI Database module is expected to be live in September 2021 and made publicly available in October.

Device manufacturers can enter Basic Unique Device Identification Device Identifier (Basic UDI-DI) and UDI-DI information into EUDAMED using real data.

According to the European Commission, this is a Minimum Viable Product (MVP), so additional functionality will be added later, but it does allow full registration of devices. Still, there are issues to be aware of and concerns about how this module will (or will not) evolve as we advance toward a fully functional EUDAMED.

The discussion will include:

  • Medical Device Regulation (MDR) and EUDAMED
  • Actor registration – How to make best use of it
  • UDI Registration in EUDAMED – Why and how to use it now
  • EUDAMED future steps


About the presenters

Lionel Tussau, Director, Strategic Industries, atrify

Lionel is leading the global healthcare strategy at the product content solution provider atrify, a company enabling UDI registrations into regulatory databases (such as EUDAMED) and GDSN connections between manufacturers, wholesalers, GPOs, and hospitals. He represents atrify in MedTech Europe (chairman of the EUDAMED IT Expert group), is an observer in the EUDAMED MDCG working group, and is a member of the GS1 Global Healthcare Leadership Team.

Jay Crowley, Vice President of Medical Device Solutions and Services, USDM Life Sciences

Jay was Senior Advisor for Patient Safety in the Food and Drug Administration’s Center for Devices and Radiological Health. Jay developed the framework and authored key requirements for the FDA’s Unique Device Identification system.

Hat Ihnen dieser Beitrag gefallen?

Mit Ihrer Bewertung hilfen Sie uns, unsere Inhalte noch weiter zu verbessern.

Rebekka Eisenacher

Rebekka Eisenacher

Weitere Artikel